hiv-1

Documents about hiv-1

• Clinical Study of TUTI-16 in Asymptomatic HIV-1 Infected Subjects#919072ClinicalTrials.gov
• HIV-2 infection as a comparative lens for functional HIV-1 remission.#152256NCBI PubMed Central
• Effect of Reducing Nucleotide Exposure on Bone Health (ReNew)#993646ClinicalTrials.gov
• A Clinical Trial to Evaluate the Safety and Immunogenicity of Glycan-trimmed HIV-1 Nanoparticle Vaccine (UVAX-1107), Followed by Homologous or Wild-type HIV-1 Nanoparticle Vaccine (UVAX-1197) Boost, Each Adjuvanted With 3M-052-AF + Alum in Adult Participants Without HIV#238193ClinicalTrials.gov
• Clinical Trial to Evaluate the Safety and Immunogenicity of Ferritin Nanoparticles Expressing Native-like HIV-1 Envelope Trimers Followed by Boost With mRNA Lipid Nanoparticles Encoding a Native-like HIV-1 Envelope Trimer in Adults Without HIV#407757ClinicalTrials.gov
• Virological and Clinical Anti-Hepatitis B Virus (HBV) Efficacy of Tenofovir and Emtricitabine in Patients With HIV/HBV co-Infection#845657ClinicalTrials.gov
• A Single-arm, Open-label, Study to Assess the Pharmacokinetics of Darunavir and Ritonavir, Darunavir and Cobicistat, Etravirine, and Rilpivirine in HIV-1 Infected Pregnant Women#862998ClinicalTrials.gov
• The Gene Encoding the Antisense Protein ASP of HIV-1: Origin, Distribution and Maintenance#161412HAL (France)
• Evaluating HIV-1 Neutralization Antibody Breadth in Response to HIV gp120 Protein Vaccine in HIV-uninfected Adults With Quiescent Systemic Lupus Erythematosus#405217ClinicalTrials.gov
• T-20 in HIV Patients With Prior Drug Treatment and/or Resistance to Each of the Three Classes of Anti-HIV Drugs#805763ClinicalTrials.gov
• Study of B/F/TAF in Participants Switching From CAB + RPV to B/F/TAF for HIV-1 Infection (EMPOWER)#840088ClinicalTrials.gov
• National Multicenter Trial Evaluating Two Treatments in Patients With Primary Human Immunodeficiency Virus (HIV-1) Infection#882557ClinicalTrials.gov
• PET Imaging of Radiolabeled Anti-HIV-1 Envelope Monoclonal Antibody (VRC01)#896864ClinicalTrials.gov
• Study to Evaluate Safety, Tolerability and Pharmacokinetics of VM-1500A-LAI Single and Multiple Ascending Doses in Healthy Subjects#907795ClinicalTrials.gov
• The Safety and Effectiveness of Fozivudine Tidoxil in HIV-1 Infected Patients#804761ClinicalTrials.gov
• HIV Transmission in the Era of Scaling up Antiretroviral Therapy in Ethiopia#914430ClinicalTrials.gov
• A Comparison of Emtricitabine and Stavudine Used With Didanosine Plus Efavirenz in HIV-Infected Patients Who Have Not Taken Anti-HIV Drugs#906316ClinicalTrials.gov
• Hormone Replacement Therapy and Anti-HIV Drugs in HIV-Infected, Postmenopausal Women#994509ClinicalTrials.gov
• A Phase III Randomized Double-Blind, Multicenter Study to Evaluate the Safety and Efficacy of 3TC/ZDV/1592U89 and 3TC/ZDV/IDV in HIV-1 Infected Antiretroviral Therapy-Naive Subjects.#830998ClinicalTrials.gov
• A Multicenter, Randomized, Placebo-Controlled, Double-Blind Trial to Evaluate the Safety and Immunogenicity of a Recombinant Vaccinia-HIV-1 IIIB Env/Gag/Pol Vaccine (TBC-3B)#853572ClinicalTrials.gov
• Adding MAraViroc &/or METformin for Hepatic Steatosis in People Living With HIV#172541ClinicalTrials.gov
• HIV-1 Vaccine Test in Uninfected Adult Volunteers#300319ClinicalTrials.gov
• Test Albuvirtide in Experienced Patients#859961ClinicalTrials.gov
• Tissue Drug Levels of HIV Medications#893137ClinicalTrials.gov
• Poor Sleep and Inflammation in HIV-Infected Adults#908555ClinicalTrials.gov
• Zadaxin and HIV-positive Patients With Immune Reconstitution Disorder#1007285ClinicalTrials.gov
• Analysis of HIV-1 Replication During Antiretroviral Therapy#1010799ClinicalTrials.gov
• A Safety and Immunogenicity Study of a Plasmid DNA Prime and MVA Boost Vaccine in HIV-1 Infected Adults on ART#966849ClinicalTrials.gov
• HIV reservoir dynamics according to the timing of antiretroviral therapy initiation or modification#161383HAL (France)
• Safety of and Immune Response to an HIV-1 DNA Vaccine (VRC HIVDNA009-00-VP) in HIV Uninfected Adults#208290ClinicalTrials.gov
• A Phase Il of a Therapeutic, Recombinant, Biologically Active HIV-1 Tat Protein Vaccine in HIV-Infected, Anti-Tat Negative, ARV-Treated Adult Volunteers#454058ClinicalTrials.gov
• Study to Compare an Oral Weekly Islatravir/Lenacapavir Regimen With Bictegravir/Emtricitabine/Tenofovir Alafenamide in Virologically Suppressed People With HIV-1#900187ClinicalTrials.gov
• Phase I Study of HIV 1 Antigen Expanded Specific T Cell Therapy#839587ClinicalTrials.gov
• Safety, Tolerability and Immunogenicity of MVA.HTI and ChAdOx1.HTI With Vesatolimod in HIV-1 Positive Patients#474807ClinicalTrials.gov
• Assessment of Age-related Hearing Loss in HIV-1 Patients#860149ClinicalTrials.gov
• Modulation of Immune Activation by Aspirin#892470ClinicalTrials.gov
• Study of Hepatitis C Virus (HCV) Viral Kinetics in HIV/HCV and HCV Patients#917834ClinicalTrials.gov
• A Phase I Safety and Immunogenicity Trial of UBI HIV Lipopeptide Vaccine Component P3C541b in HIV-1 Seronegative Human Subjects#162531ClinicalTrials.gov
• Study of the HIV gp120/NefTat/AS02A Vaccine to Treat Individuals With Chronic HIV-1 Infection on Highly Active Antiretroviral Therapy (HAART)#307319ClinicalTrials.gov
• Evaluating the Safety and Immunogenicity of an HIV-1 gp41 MPER-656 Liposome Vaccine in Healthy, HIV-uninfected Adult Participants#471496ClinicalTrials.gov
• Endothelial Function, Lipoproteins, and Inflammation With Low HDL Cholesterol in HIV: ER Niacin Versus Fenofibrate#885536ClinicalTrials.gov
• Safety and Effectiveness of TRIZIVIR (Abacavir/Lamivudine/Zidovudine) With Efavirenz in HIV-Infected Patients Who Have Never Taken Anti-HIV Drugs#803745ClinicalTrials.gov
• A Study of Abacavir Plus Indinavir Sulfate Plus Efavirenz in HIV-Infected Patients#865978ClinicalTrials.gov
• Safety and Immunogenicity of Stabilized CH505 TF chTrimer Vaccination in Adults Living With HIV-1 on Suppressive Antiretroviral Therapy#123543ClinicalTrials.gov
• Study to Compare Bictegravir/Lenacapavir Versus Current Therapy in People With HIV-1 Who Are Successfully Treated With a Complicated Regimen#812233ClinicalTrials.gov
• A Phase 1, Randomized, Blinded, Dose-escalation Study of rAAV1-PG9DP Recombinant AAV Vector Coding for PG9 Antibody in Healthy Male Adults.#878809ClinicalTrials.gov
• HIV Treatment Retention Interventions for Women Living With HIV (Siyaphambili Study)#891503ClinicalTrials.gov
• A Phase 1/2a Study of PGT121, VRC07-523LS and PGDM1400 Monoclonal Antibodies in HIV-uninfected and HIV-infected Adults#904364ClinicalTrials.gov
• Active Immunization of HIV-1 Infected, Pregnant Women With CD4 Lymphocyte Counts >= 400/mm3: A Phase I Study of Safety and Immunogenicity of MN rgp120/HIV-1 Vaccine (NOTE: Some Patients Receive Placebo)#875162ClinicalTrials.gov
• Safety and Pharmacokinetics of a Human Monoclonal Antibody, VRC-HIVMAB080-00-AB (VRC01LS), With Broad HIV-1 Neutralizing Activity, Administered Intravenously or Subcutaneously to Healthy Adults#886337ClinicalTrials.gov